Long-term toxicity of [177Lu-DOTA0,Tyr3]octreotate in rats

This publication has 30 references indexed in Scilit:

• Survival and Response After Peptide Receptor Radionuclide Therapy With [90Y-DOTA0,Tyr3]Octreotide in Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors
  Seminars in Nuclear Medicine, 2006
• Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
  Journal of Clinical Oncology, 2005
• Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues
  Nephrology Dialysis Transplantation, 2004
• Quality of Life in Patients With Gastroenteropancreatic Tumors Treated With [¹⁷⁷Lu-DOTA⁰,Tyr³]octreotate
  Journal of Clinical Oncology, 2004
• Radiation nephropathy
  Seminars in Nephrology, 2003
• Anti-tumor effect and increased survival after treatment with [177Lu-DOTA0,Tyr3]octreotate in a rat liver micrometastases model
  International Journal of Cancer, 2003
• Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine
  European Journal of Nuclear Medicine and Molecular Imaging, 2003
• Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience
  Seminars in Nuclear Medicine, 2002
• End-stage renal disease after treatment with 90 Y-DOTATOC
  European Journal of Nuclear Medicine and Molecular Imaging, 2001
• Tolerance of normal tissue to therapeutic irradiation
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991